MedPage Today - Latest Medical News/Health News Headlines
Latest Headlines News
-
Are NSAIDs Genuinely Too Dangerous in Inflammatory Bowel Disease?
(MedPage Today) -- At least some patients with inflammatory bowel disease (IBD) can safely use common drugs for musculoskeletal aches and pains, a large study of insurance claims data suggested, contradicting a widespread concern that these products... -
Next-Generation KRAS G12C Inhibitor Shows 'Robust' Efficacy in Advanced Lung Cancer
(MedPage Today) -- SAN DIEGO -- Treatment with investigational elisrasib, a next-generation KRAS G12C inhibitor, showed efficacy in patients with advanced non-small cell lung cancer (NSCLC) with and without previous exposure to other KRAS G12C... -
Dr. Oz Announces 50-State Audit of Medicaid Program Oversight
(MedPage Today) -- The Trump administration will require all 50 states to explain their plans to revalidate some of their Medicaid providers in a national escalation of anti-fraud efforts that have so far largely focused on specific states, Mehmet... -
GLP-1s and Muscle Loss; 'Ozempic Personality'; Acromegaly and Cancer Risk
(MedPage Today) -- Real-world data suggested the dual GLP-1/GIP receptor agonist tirzepatide (Mounjaro, Zepbound) was associated with greater weight loss, but also muscle loss, compared with semaglutide (Ozempic, Wegovy), according to a medical... -
Best Exercise Timing; GLP-1 Pill's Heart Safety; Pop Star's Cardiovascular Illness
(MedPage Today) -- A small trial suggested that timing exercise to match body clock chronotype enhanced cardiometabolic and sleep-related outcomes. (Open Heart)
The Society of Thoracic Surgeons published its new guideline for preventing and treating... -
Mycoplasma Pneumonia Recovery Faster With Corticosteroid
(MedPage Today) -- Adjunctive corticosteroid therapy with betamethasone sped up resolution of hypoxemia in hospitalized adults with Mycoplasma pneumoniae community-acquired pneumonia (CAP), a randomized trial from Sweden showed.
Time to resolution... -
CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group
(MedPage Today) -- SAN DIEGO -- Ciltacabtagene autoleucel (cilta-cel, Carvykti) as primary therapy induced deep and durable responses in every patient in a small phase II trial of high-risk smoldering multiple myeloma, a precursor to the active... -
Fact-Check: RFK Jr. Says U.S. Is Handling Measles Better Than the Rest of the World
(MedPage Today) -- Health Secretary Robert F. Kennedy Jr. has said that the U.S., under his leadership, is limiting the spread of measles better than any other country in the world.
His comment came Friday as he testified in his first congressional...